D-0399-2025 Class II Ongoing
FDA drug recall D-0399-2025 was initiated by American Regent, Inc. on Apr 18, 2025 and is designated Class II. Reason for recall: Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. The recall status is ongoing. Affected quantity: 7,249 (cartons of 10 x 10 mL vials).
Recall details
- Product Type
- Drugs
- Report Date
- May 7, 2025
- Initiation Date
- Apr 18, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,249 (cartons of 10 x 10 mL vials)
Product description
niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]
Reason for recall
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Distribution pattern
Nationwide in the USA
Code information
Lots, expiry: Lot 24086N0C0, 7/31/2025; Lot 24076N0C0, Lot 24090N0C0, 8/31/2025, Lot 25011N0C0, 6/30/2026;
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0399-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026